These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32304284)

  • 1. Reduced uptake of [11C]-ABP688, a PET tracer for metabolic glutamate receptor 5 in hippocampus and amygdala in Alzheimer's dementia.
    Treyer V; Gietl AF; Suliman H; Gruber E; Meyer R; Buchmann A; Johayem A; Unschuld PG; Nitsch RM; Buck A; Ametamey SM; Hock C
    Brain Behav; 2020 Jun; 10(6):e01632. PubMed ID: 32304284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of mGluR5 changes during epileptogenesis using [11C]ABP688 PET in pilocarpine-induced epilepsy rat model.
    Choi H; Kim YK; Oh SW; Im HJ; Hwang DW; Kang H; Lee B; Lee YS; Jeong JM; Kim EE; Chung JK; Lee DS
    PLoS One; 2014; 9(3):e92765. PubMed ID: 24663806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
    Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
    J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain mGluR5 in mice with amyloid beta pathology studied with in vivo [
    Fang XT; Eriksson J; Antoni G; Yngve U; Cato L; Lannfelt L; Sehlin D; Syvänen S
    Neuropharmacology; 2017 Feb; 113(Pt A):293-300. PubMed ID: 27743932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a bolus/infusion protocol for 11C-ABP688, a PET tracer for mGluR5.
    Burger C; Deschwanden A; Ametamey S; Johayem A; Mancosu B; Wyss M; Hasler G; Buck A
    Nucl Med Biol; 2010 Oct; 37(7):845-51. PubMed ID: 20870160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of age/sex and the regional distribution of mGluR5 availability in the healthy human brain measured by high-resolution [(11)C]ABP688 PET.
    DuBois JM; Rousset OG; Rowley J; Porras-Betancourt M; Reader AJ; Labbe A; Massarweh G; Soucy JP; Rosa-Neto P; Kobayashi E
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):152-162. PubMed ID: 26290423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
    Ametamey SM; Treyer V; Streffer J; Wyss MT; Schmidt M; Blagoev M; Hintermann S; Auberson Y; Gasparini F; Fischer UC; Buck A
    J Nucl Med; 2007 Feb; 48(2):247-52. PubMed ID: 17268022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of metabotropic glutamate receptor type 5 abnormalities in behavioral variant FTD.
    Leuzy A; Zimmer ER; Dubois J; Pruessner J; Cooperman C; Soucy JP; Kostikov A; Schirmaccher E; Désautels R; Gauthier S; Rosa-Neto P
    Brain Struct Funct; 2016 Apr; 221(3):1387-402. PubMed ID: 25596865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder.
    Akkus F; Mihov Y; Treyer V; Ametamey SM; Johayem A; Senn S; Rösner S; Buck A; Hasler G
    Transl Psychiatry; 2018 Jan; 8(1):17. PubMed ID: 29317611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-retest variability of [
    Smart K; Cox SML; Nagano-Saito A; Rosa-Neto P; Leyton M; Benkelfat C
    Synapse; 2018 Sep; 72(9):e22041. PubMed ID: 29935121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
    DeLorenzo C; DellaGioia N; Bloch M; Sanacora G; Nabulsi N; Abdallah C; Yang J; Wen R; Mann JJ; Krystal JH; Parsey RV; Carson RE; Esterlis I
    Biol Psychiatry; 2015 Feb; 77(3):266-275. PubMed ID: 25156701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo metabotropic glutamate receptor type 5 abnormalities localize the epileptogenic zone in mesial temporal lobe epilepsy.
    Lam J; DuBois JM; Rowley J; González-Otárula KA; Soucy JP; Massarweh G; Hall JA; Guiot MC; Rosa-Neto P; Kobayashi E
    Ann Neurol; 2019 Feb; 85(2):218-228. PubMed ID: 30597619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progression of obsessive compulsive disorder-like grooming in Sapap3 knockout mice: A longitudinal [
    Glorie D; Verhaeghe J; Miranda A; Kertesz I; Wyffels L; Stroobants S; Staelens S
    Neuropharmacology; 2020 Oct; 177():108160. PubMed ID: 32454126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabotropic Glutamate Receptor Type 5 (mGluR5) Cortical Abnormalities in Focal Cortical Dysplasia Identified In Vivo With [11C]ABP688 Positron-Emission Tomography (PET) Imaging.
    DuBois JM; Rousset OG; Guiot MC; Hall JA; Reader AJ; Soucy JP; Rosa-Neto P; Kobayashi E
    Cereb Cortex; 2016 Oct; 26(11):4170-4179. PubMed ID: 27578494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of brain mGluR5 binding in a pilot study of late-life major depressive disorder using positron emission tomography and [¹¹C]ABP688.
    DeLorenzo C; Sovago J; Gardus J; Xu J; Yang J; Behrje R; Kumar JS; Devanand DP; Pelton GH; Mathis CA; Mason NS; Gomez-Mancilla B; Aizenstein H; Mann JJ; Parsey RV
    Transl Psychiatry; 2015 Dec; 5(12):e693. PubMed ID: 26645628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetylcysteine- and MK-801-induced changes in glutamate levels do not affect in vivo binding of metabotropic glutamate 5 receptor radioligand 11C-ABP688 in rat brain.
    Wyckhuys T; Verhaeghe J; Wyffels L; Langlois X; Schmidt M; Stroobants S; Staelens S
    J Nucl Med; 2013 Nov; 54(11):1954-61. PubMed ID: 24050937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marked global reduction in mGluR5 receptor binding in smokers and ex-smokers determined by [11C]ABP688 positron emission tomography.
    Akkus F; Ametamey SM; Treyer V; Burger C; Johayem A; Umbricht D; Gomez Mancilla B; Sovago J; Buck A; Hasler G
    Proc Natl Acad Sci U S A; 2013 Jan; 110(2):737-42. PubMed ID: 23248277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging.
    Chen MK; Mecca AP; Naganawa M; Finnema SJ; Toyonaga T; Lin SF; Najafzadeh S; Ropchan J; Lu Y; McDonald JW; Michalak HR; Nabulsi NB; Arnsten AFT; Huang Y; Carson RE; van Dyck CH
    JAMA Neurol; 2018 Oct; 75(10):1215-1224. PubMed ID: 30014145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limbic system mGluR5 availability in cocaine dependent subjects: a high-resolution PET [(11)C]ABP688 study.
    Milella MS; Marengo L; Larcher K; Fotros A; Dagher A; Rosa-Neto P; Benkelfat C; Leyton M
    Neuroimage; 2014 Sep; 98():195-202. PubMed ID: 24795154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study.
    Deschwanden A; Karolewicz B; Feyissa AM; Treyer V; Ametamey SM; Johayem A; Burger C; Auberson YP; Sovago J; Stockmeier CA; Buck A; Hasler G
    Am J Psychiatry; 2011 Jul; 168(7):727-34. PubMed ID: 21498461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.